HomeCompareIGAP vs ORCC

IGAP vs ORCC: Dividend Comparison 2026

IGAP yields 61.73% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IGAP wins by $687.5K in total portfolio value
10 years
IGAP
IGAP
● Live price
61.73%
Share price
$3.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$708.9K
Annual income
$169,317.01
Full IGAP calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — IGAP vs ORCC

📍 IGAP pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIGAPORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IGAP + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IGAP pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IGAP
Annual income on $10K today (after 15% tax)
$5,246.91/yr
After 10yr DRIP, annual income (after tax)
$143,919.46/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, IGAP beats the other by $143,918.57/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IGAP + ORCC for your $10,000?

IGAP: 50%ORCC: 50%
100% ORCC50/50100% IGAP
Portfolio after 10yr
$365.2K
Annual income
$84,659.02/yr
Blended yield
23.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

IGAP
No analyst data
Altman Z
-20.7
Piotroski
2/9
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IGAP buys
0
ORCC buys
0
No recent congressional trades found for IGAP or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIGAPORCC
Forward yield61.73%9.79%
Annual dividend / share$2.00$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$708.9K$21.4K
Annual income after 10y$169,317.01$1.04
Total dividends collected$591.0K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: IGAP vs ORCC ($10,000, DRIP)

YearIGAP PortfolioIGAP Income/yrORCC PortfolioORCC Income/yrGap
1← crossover$16,873$6,172.84$11,190$489.61+$5.7KIGAP
2$27,788$9,733.96$12,229$256.01+$15.6KIGAP
3$44,715$14,982.11$13,216$130.74+$31.5KIGAP
4$70,377$22,531.41$14,207$66.02+$56.2KIGAP
5$108,445$33,141.97$15,234$33.17+$93.2KIGAP
6$163,764$47,728.25$16,317$16.62+$147.4KIGAP
7$242,588$67,359.95$17,468$8.32+$225.1KIGAP
8$352,823$93,254.02$18,695$4.16+$334.1KIGAP
9$504,278$126,756.91$20,006$2.08+$484.3KIGAP
10$708,894$169,317.01$21,407$1.04+$687.5KIGAP

IGAP vs ORCC: Complete Analysis 2026

IGAPStock

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Europe and the Asia Pacific. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Full IGAP Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this IGAP vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IGAP vs SCHDIGAP vs JEPIIGAP vs OIGAP vs KOIGAP vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.